down arrow

Sichuan Kelun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PW7
  • SHE: 002422
CNY
42.00
-0.48 (-1.13%)

Sep 22

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sichuan Kelun Pharmaceutical Co., Ltd.

Why is Sichuan Kelun Pharmaceutical Co., Ltd. ?

1
The company has declared Negative results for the last 6 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 2,608.1 MM
  • NET PROFIT(9M) At CNY 1,141.6 MM has Grown at -32.93%
  • ROCE(HY) Lowest at 6.58%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Sichuan Kelun Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sichuan Kelun Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sichuan Kelun Pharmaceutical Co., Ltd.
12.63%
0.98
41.03%
China Shanghai Composite
3.23%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.48%
EBIT Growth (5y)
4.76%
EBIT to Interest (avg)
12.24
Debt to EBITDA (avg)
0.57
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
0.74
Tax Ratio
20.20%
Dividend Payout Ratio
55.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.45%
ROE (avg)
10.61%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
2.31
EV to EBIT
32.20
EV to EBITDA
19.40
EV to Capital Employed
2.62
EV to Sales
2.84
PEG Ratio
NA
Dividend Yield
1.22%
ROCE (Latest)
8.14%
ROE (Latest)
6.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at -18.16 %

RAW MATERIAL COST(Y)

Fallen by 1.98% (YoY

CASH AND EQV(HY)

Highest at CNY 18,269.22 MM

PRE-TAX PROFIT(Q)

Highest at CNY 1,057.17 MM

NET PROFIT(Q)

Highest at CNY 664.51 MM

EPS(Q)

Highest at CNY 0.42

-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 2.47 times

Here's what is working for Sichuan Kelun Pharmaceutical Co., Ltd.

Debt-Equity Ratio
Lowest at -18.16 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
Highest at CNY 1,057.17 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit
At CNY 1,057.17 MM has Grown at 84.84%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 664.51 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit
At CNY 664.51 MM has Grown at 61.55%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.42
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 18,269.22 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 1.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at CNY 369.54 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (CNY MM)

Depreciation
At CNY 369.54 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Sichuan Kelun Pharmaceutical Co., Ltd.

Debtors Turnover Ratio
Lowest at 2.47 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Non Operating Income
Highest at CNY 0.63 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Footer loading